32nd infection prevention and control nurses college...

39
Kupu Taurangi Hauora o Aotearoa 32nd Infection Prevention and Control Nurses College Conference ‘Building Beyond’ The Commission’s Role in IPC

Upload: lamnhu

Post on 28-Nov-2018

212 views

Category:

Documents


0 download

TRANSCRIPT

Kupu Taurangi Hauora o Aotearoa

32nd Infection Prevention and Control Nurses College Conference

‘Building Beyond’

The Commission’s Role in IPC

NZ Health Quality & Safety Commission

• Formally established under the NZ Public Health & Disability Act 2010

• Triple Aim:

– Improved quality, safety and experience of care

– Improved health and equity for all populations

– Better value for public health resources

Why establish a new national QI agency?

HQSC role and purpose

To lead and coordinate work across the health and disability sector to:

• monitor and improve the quality and safety of health and disability services

• help providers across the health and disability sector to improve the quality and safety of health and disability services

Measurable improvement

• For every patient, at the individual, population and systems level

• Open for better care campaign wrapped around the improvement programmes

• Publicly reported quality & safety markers: visibility and priority at senior levels in DHBs

• Clinical leadership

• Multidisciplinary teamwork

• Consumer engagement

How the Commission adds value

Shining the light on variation and key areas for improvement

Being an intelligent commentator and advocate for change

Lending a hand by making expert advice, guidance and tools available

Approach

• Mix of programmes

– Strategic

– Long Term

– Improvement

• Annual review of portfolio of programmes

• Continuous refreshing of improvement projects to keep pace with emerging trends, new knowledge and stakeholder expectations

7

HQSC Infection Prevention and Control• Overarching IPC programme focus:

– Raising the strategic profile and importance of IPC

– Supporting clinical leadership

– Measuring and monitoring progress

– Capability building in quality improvement

• Current improvement projects:

– Surgical Site infection Improvement Programme (SSIIP)

– Hand Hygiene New Zealand (HHNZ)

• Previous improvement projects:

– Target CLAB Zero

What is an ‘Improvement Project’? • Focus on a specific area or topic for improvement

– Known actions that if implemented will reduce harm– Call to action for people to make change– Builds leadership, re-usable networks and capability for

improvement– Uses a recognised improvement methodology– Improvement can be measured

• National scale, accelerated pace• Time limited, building sustainability• Significant resource investment• Quality and Safety Markers (QSMs) – process and outcome

measures

9

2011-12 2012-13 2013-14 2014-15 2015-16 2016-17

IPC:

• Hand Hygiene delivery delivery delivery evaluation/transition

transition/BAU

BAU

• CLAB start-up delivery transition / evaluation

BAU BAU BAU

• SSI (Ortho) scoping start-up delivery delivery delivery/ transition

evaluation/ BAU

Med. Safety:

• Hospital eMedicines

delivery delivery delivery / transition

evaluation BAU

• OpioidCollaborative

scoping start-up delivery delivery transition / evaluation

Perioperative Harm

scoping start-up delivery delivery transition / evaluation

Falls scoping start-up delivery delivery transition / evaluation

New Programme 1 scoping start-up delivery delivery

New Programme 2 scoping start-up delivery

Pipeline of new improvement programmes

• Emerging priorities

• Refining of current prioritisation criteria

• Shorter list of 2-3 probable new programmes

• Further scoping of value proposition

Implementation

Long-list of feasible

proposals for prioritisation

2-3 projects prioritised for

implementation

Project evaluation

Pipeline of proposals

collected during the year

Transfer to

the sector

Working list of proposed initiativesPotential Improvement Projects

High Risk Meds Delay cases

Pressure injuries Patient identification

Deteriorating patient Sepsis

VTE Transition points of care

Polypharmacy Blood products

Catheter associated urinary tract infections

Caesarean Section SSIs

Ventilator associated complications (VAC)

PIV Infections

Informed by the Commission’s Strategic IPC Governance Group, membership of which includes:

• Adrienne Morgan, IPC consultant, IPCNC private sector representative

• Arthur Morris, Clinical Microbiologist, Clinical Lead SSII Programme

• Don Mackie, Chief Medical Officer ,Ministry of Health (ex officio)

• Geoff Cardwell, Consumer representative

• Jane Pryer, Senior Advisor - Healthcare Associated Infections & Communicable Diseases

• Jenny Parr, Assistant Director of Nursing & Director of IPC WDHB

• Jo Stodart, Charge Nurse Manager IPC Service SDHB, IPCNC DHB representative

• Joshua Freeman, Clinical Microbiologist ADHB, Clinical Lead HHNZ

• Lorraine Rees, Charge Nurse Manager IPC Service MCDHB, IPCNC DHB representative

• Mo Neville, Assistant Group Manager Quality and Patient Safety Waikato DHB

• Nick Kendall, Manager, Treatment Injury, ACC

• Richard Everts, Infectious Diseases Physician, ASID representative

• Sally Roberts, Infectious Diseases Physician and Clinical Microbiologist, Clinical Head of Microbiology ADHB, National Clinical Lead IPC Programme

• Trevor English, consultant (prev. GM Hospital Support and Laboratories at Canterbury DHB)

• HQSC : Gabrielle Nicholson; Karen Orsborn; Gillian Bohm; Deborah Jowitt; Rachel Hill

Target CLAB Zero

• All 20 DHBs

• IHI methodology:

‘CLAB Collaborative’

• ICU focus

• Spread to other clinical areas

• Standard of care

Reducing CLAB to <1/1000 central line days

“Better for patients …”“It’s much better for patients …

if they are transferred from another ICU, we can see the insertion

checklist and feel confident about leaving the line in place.”

Merilyn Beken, ICU Nurse Specialist, Auckland DHB

Hand Hygiene New Zealand• WHO ‘5 moments for hand

hygiene’ programme:

– Senior sponsorship

– POC hand gel

– Education/audit & feedback

– Champions/Clinical Leadership

– Patient participation

Progress over time

Figure 1. Trends in national aggregate and average hand hygiene performance: October 2012 to June 2015

Trends in national aggregate and average hand hygiene

performance: October 2012 to June 2015

‘Frontline ownership – Waitemata DHB’

DHB HH performance by moment

NameCorrect

moments

Total

momentsCompliance rate

Lower

confidence

interval

Upper

confidence

interval

Northern

Region

DHBs12,037 15,171 79.3% 78.7% 80%

Midland

Region

DHBs 5,099 6,361 80.2% 79.2% 81.1%

Central

Region

DHBs 7,691 9,635 79.8% 79% 80.6%

South

Island

Region

DHBs

6,673 8,193 81.4% 80.6% 82.3%

Table 2. Hand hygiene performance by geographic region

Reaching 80 percent!

Hand Hygiene 2015/16

• HHNZ website being maintained

• Database being upgraded by Hand Hygiene Australia (HHA)

• Reporting maintained and enhanced

• National coordinator role

• Communications on-going

Working regionally

• The Commission working with the sector to support the development of regional IPC networks

• First round of meetings Dec 2014/Feb 2015 in Northern, Midland, Central and Southern regions

• Focused on what would be needed to sustain practice improvement as the hand hygiene programme is transitioned from being centrally led by the Commission, to being regionally supported

Approaches to improvementand results to date

SSIIP progress to date

• All 20 DHBs engaged in the orthopaedic workstream of the programme– Canterbury and Auckland DHBs delivering the

SSIIP in partnership with HQSC

– ICNet-based national data warehouse supports data collection, analysis and reporting (local and national reports – quality and safety markers)

• Three of five DHBs (Auckland; Canterbury; Southern) engaged in cardiac workstream of the programme

SSII Programme SG members:• Dr Sally Roberts, Clinical Head of Microbiology, ADHB

• Dr Arthur Morris, Clinical Microbiologist, ADHB

• Mr Imran Ramanathan, Cardiothoracic Surgeon, ADHB and NZ Representative on the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS)

• Mr Richard Lander, Orthopaedic Surgeon, MidCentral DHB, Executive Director for Surgical Affairs, Royal Australasian College of Surgery (RACS), representing the Surgical College (replaced Dr Allan Panting NMDHB March 2015)

• Mr Kelly Vince, Orthopaedic Surgeon, Northland DHB

• Claire Underwood, IPC Clinical Nurse Specialist, Hutt Valley DHB

• Marie Russell, Perioperative Nurse, Grace Hospital, representing from the NZNO Perioperative Nurses College

• Dr Andrew McWilliams, Anaesthetist, Canterbury DHB, representing the Australia and New Zealand College of Anaesthetists (ANZCA)

*Lisa Maxwell, IPC Clinical Nurse Specialist, Waikato DHB, on SSIIP Expert Faculty

Improvement approach

• A range of improvement methodologies:

‘the right tool for the right job’

• Continuous quality improvement – shift from initial Lean Six Sigma approach to a more inclusive approach that uses a mixture of methodologies including the IHI Model for Improvement (PDSA cycles)and Frontline Ownership

Local Barriers to EngagementSome similar to other IPC initiatives:

– ensuring senior executives actively involved

– overcoming resistance to working together in a multidisciplinary way

– creating local ‘ownership’ of improvement

Issues particular to SSIIP:

– time involved in manual inputting of data

– translating IT needs into action

QSMs: Process Markers

• QSMs for SSIIP confirmed in consultation with the sector as:

–Antibiotic prophylaxis given on time (0-60 minutes before knife to skin)

–Correct dose of recommended antibiotic

–Alcohol-based skin preparation – either chlorhexidine or povidone iodine

QSM Compliance over time

QSM March-June

2013

October-

December

2013

January-

March

2014

October-

December

2014

On time 91% 90% 92% 95%

Dose

>=2g cefazolin

51% 68% 78% 90%

Alcohol based

skin

preparation

94% 96% 98% 98%

Post-op

duration

<24hrs

61% 84% 76% 83%

‘On time’ antibiotic prophylaxis

Correct dose of antibiotic

Use of alcohol-based skin prep

Outcome measure:Hip and knee SSI rates Mar 2013-Dec 2014

SSIIP 2015/16 …• Maintaining engagement in all 20 DHBs

• More in the consumer space

• Appointment of a new QI Advisor to

support local and regional work

• Automated data collection and reporting a

a priority for sustainability

• Improved reporting both local and

regional

• Frontline ownership?

Looking forward• Continue to raise the profile of IPC

• Focus on ‘connectedness’ - facilitate the sharing of good practice – from ‘islands of excellence’ to a more integrated network

• Put resources towards QI capability building with an IPC focus

• Consult, share, work in partnership across the sector to improve patient outcomes

Acknowledgments

• All the work being done by IPC nurses, hand hygiene champions, surgical teams and SSI champions, & others that support their efforts to improve patient safety & reduce HAIs

• Clinical Lead for IPC programme – Dr Sally Roberts

[email protected]

• Clinical Lead for SSII programme – Dr Arthur Morris

[email protected]

• Clinical Lead for tHand Hygiene Programme – Dr Josh Freeman

[email protected]